Amlodipine in patients with stable angina pectoris treated with beta-blockers

Scandinavian Cardiovascular Journal

Volumn 32, Issue 1, 1998, Pages 41-48

  Rossinen, J ^a   Partanen, J ^b   Nieminen, M S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b JORVI HOSPITAL   (Finland)

Author keywords

Amlodipine; Coronary heart disease; Ischaemia

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AMBULATORY MONITORING; ANGINA PECTORIS; ARTICLE; BICYCLE ERGOMETRY; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; HEART RATE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION;

ADRENERGIC BETA-ANTAGONISTS; AMLODIPINE; ANGINA PECTORIS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CORONARY ANGIOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, DOPPLER, PULSED; ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MIDDLE AGED; VASODILATOR AGENTS;

EID: 0031881308     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017439850140337     Document Type: Article

References (30)

1. Bernink PJLM, de Weerd P, ten Cate FJ, et al. An 8-week double-blind study of amlodipine and diltiazem in patients with stable exertional angina pectoris. J Cardiovasc Pharmacol 1991; 17 Suppl 1: S53-S56.
2. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992; 85: 164-171.
3. Bode WE, Bough EW, Reichman MJ, et al. Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study. Circulation 1985; 71: 1197-1205.
4. Boden WE, Korr KS, Bough EW. Nifedipine-induced hypotension and myocardial ischemia in refractory angina pectoris. JAMA 1985; Vol 253, No 8.: 1131-1135.
5. Cocco G, Alfiero R. A double-blind dose-response study of amlodipine in patients with stable angina pectoris. Eur Heart J 1991; 12: 169-174.
6. Davies RF, Habibi H, Klinke WP, Dessain P, Nadeau C, Phaneuf DC, and the CASIS investigators. Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. J Am Coll Cardiol 1995; 25: 619-25.
7. Deanfield JE, Detry J-MRG, Lichtlen PR, and the CAPE study group. Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind circadian anti-ischemia program in Europe (CAPE trial). J Am Coll Cardiol 1994; 24: 1460-1467.
8. Deedwania PC, Cheitlin MD, Das SK, et al. Amlodipine once a day in stable angina: double-blind crossover comparison with placebo. Clin Cardiol 1993; 16: 599-602.
9. DiBianco R, Schoomaker FW, Singh JB, et al. Amlodipine combined with beta-blockade for chronic angina: results of a multicenter, placebo-controlled, randomized double-blind study. Clin Cardiol 1992; 15: 519-524.
10. Ezekowitz MD, Hossack K, Mehta JL, et al. Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial. Am Heart J 1995; 129: 527-535.
11. Feigenbaum H. Appendix, 660. In: Echocardiography, 5th Ed. Philadelphia: Lea & Febiger, 1994.
12. Floras JS. Antihypertensive treatment, myocardial infarction and nocturnal myocardial ischemia. Lancet 1988; 2: 994-996.
13. Huikuri HV, Valkama JO, Airaksinen KEJ, et al. Frequency domain measures of heart rate variability before the onset of non-sustained and sustained ventricular tachycardia in patients with coronary artery disease. Circulation 1993; 87: 1220-1228.
14. Kennedy HL. Ambulatory electrocardiography strategies used in assessing silent myocardial ischaemia. Eur Heart J 1988; 9 Suppl N: 70-77.
15. Kinnard DR, Harris M, Hossack KF. Endurance testing for evaluation of antianginal therapy with amlodipine, a calcium channel blocking agent. J Am Coll Cardiol 1988; 12: 791-796.
16. Lehmann G, Reiniger G, Beyerle A, Rudolph W. Pharmacokinetics and additional anti-ischemic effectiveness of amlodipine, a once-daily calcium antagonist, during acute and long-term therapy of stable angina pectoris in patients pre-treated with beta-blocker. Eur Heart J 1993; 14: 1531-1535.
17. Majdlessi-Simon T, Fillette F, Mary-Krause M, Lechat P, Jaillon P, Amlor-Holter Study investigators. Effects of amlodipine on transient myocardial ischaemia in patients with a severe coronary condition treated with a beta-blocker. Eur Heart J 1995; 16: 1780-1788.
18. Mehta JL, Lopez LM. A double-blind evaluation of amlodipine in patients with chronic, stable angina: sustained efficacy and lack of "withdrawal phenomenon" upon abrupt discontinuation. Clin Cardiol 1994; 17 Suppl III: III-17-III-22.
19. Meluzín J, Štejfa M, Nov́k et al. Amlodipine in patients with stable angina pectoris treated with nitrates and beta-blockers. The influence on exercise tolerance, systolic and diastolic functions of the left ventricle. Int J Cardiol 1992; 37: 101-109.
20. Nesto RW, White HD, Ganz P, et al. Addition of nifedipine to maximal beta-blocker-nitrate therapy: effects on exercise capacity and global left ventricular performance at rest and during exercise. Am J Cardiol 1985; 55: 3E-8E.
21. North of England Stable Angina Guideline Development Group. North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management of stable angina. Br Med J 1996; 312: 827-832.
22. Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, and the prospective randomized amlodipine survival evaluation study group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996; 335: 1107-1114.
23. Ratshin RA, Rackley CE, Russel RO. Determination of left ventricular preload and afterload by quantitative echocardiography in man. Circ Res 1974; 34: 711-718.
24. Rich MW, Saini JS, Kleiger RE, Carney RM, teVelde A, Freedland KE. Correlation of heart rate variability with clinical and angiographic variables and late mortality after coronary angiography. Am J Cardiol 1988; 62: 714-717.
25. Schmidt RF, Thews G. Function of the heart. In: Human physiology. Berlin: Springer-Verlag, 1983.
26. Singh S, and the investigators of study 152. Long-term double-blind evaluation of amlodipine and nadolol in patients with stable exertional angina pectoris. Clin Cardiol 1993; 16: 54-58.
27. The CONSENSUS Trial Study Group. Effect of enalapril on mortality in severe congestive heart failure of the cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-1435.
28. Tolins M, Weir EK, Chesler E, Pierpont GL. "Maximal" drug therapy is not necessarily optimal in chronic angina pectoris. JACC 1984; 3: 1051-1057.
29. Valkama JO, Huikuri HV, Koistinen MJ, Yli-Mäyry S, Airaksinen KEJ, Myerburg RJ. Relation between heart rate variability and spontaneous and induced ventricular arrhythmias in patients with coronary artery disease. J Am Coll Cardiol 1995; 25: 437443.
30. Woodmansey PA, Stewart AG, Morice AH, Channer KS. Amlodipine in patients with angina uncontrolled by atenolol. Eur J Clin Pharmacol 1993; 45: 107-111.